104 related articles for article (PubMed ID: 38638868)
1. Channelopathy of small- and intermediate-conductance Ca
Nam YW; Downey M; Rahman MA; Cui M; Zhang M
Acta Pharmacol Sin; 2023 Feb; 44(2):259-267. PubMed ID: 35715699
[TBL] [Abstract][Full Text] [Related]
2. Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.
Cozzolino M; Panyi G
Front Pharmacol; 2024; 15():1380655. PubMed ID: 38638868
[TBL] [Abstract][Full Text] [Related]
3. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
[TBL] [Abstract][Full Text] [Related]
4. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
5. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
Hasenau AL; Nielsen G; Morisseau C; Hammock BD; Wulff H; Köhler R
Acta Physiol (Oxf); 2011 Sep; 203(1):117-26. PubMed ID: 21362152
[TBL] [Abstract][Full Text] [Related]
6. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-
Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H
Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780
[TBL] [Abstract][Full Text] [Related]
7. The combined activation of K
Pillozzi S; D'Amico M; Bartoli G; Gasparoli L; Petroni G; Crociani O; Marzo T; Guerriero A; Messori L; Severi M; Udisti R; Wulff H; Chandy KG; Becchetti A; Arcangeli A
Br J Cancer; 2018 Jan; 118(2):200-212. PubMed ID: 29161243
[TBL] [Abstract][Full Text] [Related]
8. Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness.
Cheng H; Qiu Y; Xu Y; Chen L; Ma K; Tao M; Frankiw L; Yin H; Xie E; Pan X; Du J; Wang Z; Zhu W; Chen L; Zhang L; Li G
Nat Metab; 2023 Feb; 5(2):314-330. PubMed ID: 36717749
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic K
Soret B; Hense J; Lüdtke S; Thale I; Schwab A; Düfer M
Biol Chem; 2023 Mar; 404(4):339-353. PubMed ID: 36571487
[TBL] [Abstract][Full Text] [Related]
10. IK
Gross D; Bischof H; Maier S; Sporbeck K; Birkenfeld AL; Malli R; Ruth P; Proikas-Cezanne T; Lukowski R
Cell Death Dis; 2022 Oct; 13(10):902. PubMed ID: 36302750
[TBL] [Abstract][Full Text] [Related]
11. Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis.
Lin Y; Zhao YJ; Zhang HL; Hao WJ; Zhu RD; Wang Y; Hu W; Zhou RP
Front Immunol; 2022; 13():997621. PubMed ID: 36275686
[TBL] [Abstract][Full Text] [Related]
12. Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K
Burg S; Shapiro S; Peretz A; Haimov E; Redko B; Yeheskel A; Simhaev L; Engel H; Raveh A; Ben-Bassat A; Murninkas M; Polak R; Haitin Y; Etzion Y; Attali B
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202926119. PubMed ID: 35969786
[TBL] [Abstract][Full Text] [Related]
13. How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity.
Chirra M; Newton HS; Gawali VS; Wise-Draper TM; Chimote AA; Conforti L
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892822
[TBL] [Abstract][Full Text] [Related]
14. Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy.
Navarro F; Casares N; Martín-Otal C; Lasarte-Cía A; Gorraiz M; Sarrión P; Llopiz D; Reparaz D; Varo N; Rodriguez-Madoz JR; Prosper F; Hervás-Stubbs S; Lozano T; Lasarte JJ
Oncoimmunology; 2022; 11(1):2070337. PubMed ID: 35529677
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
